Regulation of osteoblast differentiation: a novel function for fibroblast growth factor 8
- PMID: 16439448
- DOI: 10.1210/en.2005-1502
Regulation of osteoblast differentiation: a novel function for fibroblast growth factor 8
Abstract
Several members of the fibroblast growth factor (FGF) family have an important role in the development of skeletal tissues. FGF-8 is widely expressed in the developing skeleton, but its function there has remained unknown. We asked in this study whether FGF-8 could have a role in the differentiation of mesenchymal stem cells to an osteoblastic lineage. Addition of FGF-8 to mouse bone marrow cultures effectively increased initial cell proliferation as well as subsequent osteoblast-specific alkaline phosphatase production, bone nodule formation, and calcium accumulation if it was added to the cultures at an early stage of osteoblastic differentiation. Exogenous FGF-8 also stimulated the proliferation of MG63 osteosarcoma cells, which was blocked by a neutralizing antibody to FGF-8b. In addition, the heparin-binding growth factor fraction of Shionogi 115 (S115) mouse breast cancer cells, which express and secrete FGF-8 at a very high level, had an effect in bone marrow cultures similar to that of exogenous FGF-8. Interestingly, experimental nude mouse tumors of S115 cells present ectopic bone and cartilage formation as demonstrated by typical histology and expression of markers specific for cartilage (type II and IX collagen) and bone (osteocalcin). These results demonstrate that FGF-8 effectively predetermines bone marrow cells to differentiate to osteoblasts and increases bone formation in vitro. It is possible that FGF-8 also stimulates bone formation in vivo. The results suggest that FGF-8, which is expressed by a great proportion of malignant breast and prostate tumors, may, among other factors, also be involved in the formation of osteosclerotic bone metastases.
Similar articles
-
Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.J Bone Miner Res. 2004 Nov;19(11):1850-61. doi: 10.1359/JBMR.040817. Epub 2004 Aug 23. J Bone Miner Res. 2004. PMID: 15476586
-
Actions of fibroblast growth factor-8 in bone cells in vitro.Am J Physiol Endocrinol Metab. 2009 Jul;297(1):E142-50. doi: 10.1152/ajpendo.90743.2008. Epub 2009 Apr 21. Am J Physiol Endocrinol Metab. 2009. PMID: 19383871
-
Acidic fibroblast growth factor inhibits osteoblast differentiation in vitro: altered expression of collagenase, cell growth-related, and mineralization-associated genes.J Cell Biochem. 1996 Apr;61(1):152-66. doi: 10.1002/(sici)1097-4644(19960401)61:1<152::aid-jcb16>3.0.co;2-q. J Cell Biochem. 1996. PMID: 8726364
-
Gene expression in osteoblastic cells.Crit Rev Eukaryot Gene Expr. 1991;1(2):85-98. Crit Rev Eukaryot Gene Expr. 1991. PMID: 1802105 Review.
-
Fibroblast growth factor signaling controlling osteoblast differentiation.Gene. 2003 Oct 16;316:23-32. doi: 10.1016/s0378-1119(03)00748-0. Gene. 2003. PMID: 14563548 Review.
Cited by
-
The small molecule DIPQUO promotes osteogenic differentiation via inhibition of glycogen synthase kinase 3-beta signaling.J Biol Chem. 2021 Jan-Jun;296:100696. doi: 10.1016/j.jbc.2021.100696. Epub 2021 Apr 22. J Biol Chem. 2021. PMID: 33895139 Free PMC article.
-
Assessment of the Tissue Response to Modification of the Surface of Dental Implants with Carboxyethylphosphonic Acid and Basic Fibroblastic Growth Factor Immobilization (Fgf-2): An Experimental Study on Minipigs.Biology (Basel). 2021 Apr 23;10(5):358. doi: 10.3390/biology10050358. Biology (Basel). 2021. PMID: 33922433 Free PMC article.
-
Fibroblast growth factor control of cartilage homeostasis.J Cell Biochem. 2013 Apr;114(4):735-42. doi: 10.1002/jcb.24418. J Cell Biochem. 2013. PMID: 23060229 Free PMC article. Review.
-
Role of fibroblast growth factor 8 (FGF8) in animal models of osteoarthritis.Arthritis Res Ther. 2008;10(4):R90. doi: 10.1186/ar2474. Epub 2008 Aug 12. Arthritis Res Ther. 2008. PMID: 18699993 Free PMC article.
-
Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.Genes Chromosomes Cancer. 2011 Oct;50(10):757-64. doi: 10.1002/gcc.20897. Epub 2011 Jun 29. Genes Chromosomes Cancer. 2011. PMID: 21717526 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical